PER percheron therapeutics limited

10.0%

0.9¢

Ann: Notices received under S203D and S249D of Corporations Act, page-63

First 63 Last

Share
Profile

Follow
joe76

502 Posts.

87

27/02/25

12:23

Post #: 78053984
Share

Originally posted by itsagas: ↑

No one’s baiting you Sam
I promised you I would stay away until after the results
However
Emails to shareholders re Koutchen and Peter’s were without merit but just mocking the existing Board
Sam
You have said that Koutchen is a NO show… PVL have not told us what they intend to do…and I think from memory you have already casted your vote .. or have you ?

You must have been up all night writing your post..
NO I don’t really care about you changing your tune..

Why?
Because your followers have left the building
And they can vote independently from what is put before them…by both parties..
Approx 900 million soi…PvL 100 mill
Gj 40 mill … my people 90 mill… do the sums
Who do you think the 13 funds will vote for to protect their investment?

Your insecure and still hiding your true feelings ..
I just asked your opinion .. No baiting !
You were a big fan of JG when he first started and you and the unwashed group since then have continued to rubbish him saying he was only here for a lifestyle.. pocketing his salary and reaping free options for nothing in return
Well yesterday demolished that nonsense..was exactly that “nonsense”
People will vote with what’s in front of them..
its entirely their choice..

Expand

Me and my mares hold around 16.5 mil and we will be voting to
KEEP JG and CC all the way....................
When you are the CEO you dont buy 42 mil to f it up

PER Price at posting: 1.4¢ Sentiment: Hold Disclosure: Held
15 Upvote

3 Great analysis

Reply

Top Stories

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

'Not possible' to port renewable gas: ACCC takes AGN to court

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 63 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.9¢		Change -0.001(10.0%)		Mkt cap ! $9.786M

Open	High	Low	Value	Volume
1.0¢	1.0¢	0.9¢	$94.66K	10.09M

Buyers (Bids)

No.	Vol.	Price($)
4	661860	0.9¢

Sellers (Offers)

Price($)	Vol.	No.
1.0¢	1588275	6

View Market Depth

No.	Vol.	Price($)
4	661860	0.009
7	3873000	0.008
2	1142857	0.007
2	1999997	0.006
2	3200000	0.005

Price($)	Vol.	No.
0.010	1588275	6
0.011	2500000	6
0.012	2758324	6
0.013	691461	3
0.014	1572000	3

Last trade - 15.52pm 27/06/2025 (20 minute delay)

PER (ASX) Chart

Ann: Notices received under S203D and S249D of Corporations Act, page-63

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Boss extends June win streak with boosted Alta Mesa extraction rates

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

'Not possible' to port renewable gas: ACCC takes AGN to court

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Notices received under S203D and S249D of Corporations Act, page-63

Top Stories

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Boss extends June win streak with boosted Alta Mesa extraction rates

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

'Not possible' to port renewable gas: ACCC takes AGN to court

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News